A new study published in the journal Cell explores the cellular “runaway train” that allows lupus and other autoimmune diseases to spread throughout the body.
Autoimmune disease is exactly what it sounds like—the body mistakenly fighting itself. This attack may take the form of type 1 diabetes, celiac disease, rheumatoid arthritis, inflammatory bowel disease, or lupus, among others. But what begins as a local problem often eventually goes global.
“Once your body’s tolerance for its own tissues is lost, the chain reaction is like a runaway train,” co-author Michael Carroll of Boston Children’s Hospital and Harvard Medical School said in a statement.
ImmuPharma PLC (LON:IMM) is headquartered in London and has its research operations in France (ImmuPharma (France) SA) and Switzerland (ImmuPharma AG). ImmuPharma is dedicated to the development of innovative drugs to treat serious medical conditions, characterised by High unmet medical need,Low marketing costs and Relatively low development costs